These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 430270

  • 21. Aspartame. Review of safety issues. Council on Scientific Affairs.
    JAMA; 1985 Jul 19; 254(3):400-2. PubMed ID: 2861297
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of elevated plasma phenylalanine levels on other amino acids in phenylketonuric and normal subjects.
    Efron ML, Kang ES, Visakorpi J, Fellers FX.
    J Pediatr; 1969 Mar 19; 74(3):399-405. PubMed ID: 5764775
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients.
    Mackey SA, Berlin CM.
    Clin Pediatr (Phila); 1992 Jul 19; 31(7):394-9. PubMed ID: 1617863
    [Abstract] [Full Text] [Related]

  • 27. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine.
    Jagenburg R, Rödjer S.
    Clin Chem; 1977 Sep 19; 23(9):1661-5. PubMed ID: 890910
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame.
    Stegink LD, Filer LJ, Baker GL.
    J Nutr; 1983 Sep 19; 113(9):1851-60. PubMed ID: 6886827
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).
    Trefz F, de Sonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H.
    Hum Genet; 1994 Apr 19; 93(4):369-74. PubMed ID: 8168806
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V, Cochran C, Parker TF, Long DL, Ashby J, Gorman MA, Liepa GU.
    Am J Clin Nutr; 1989 Jun 19; 49(6):1302-6. PubMed ID: 2729170
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R, Regårdh CG, Rödjer S.
    Clin Chem; 1977 Sep 19; 23(9):1654-60. PubMed ID: 890909
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.